Effects of intermittent androgen suppression on the stem cell composition and the expression of the TRPM-2 (clusterin) gene in the Shionogi carcinoma

Journal of Steroid Biochemistry and Molecular Biology

Volumn 59, Issue 5-6, 1996, Pages 501-511

  Akakura, Koichiro ^a   Bruchovsky, Nicholas ^a   Rennie, Paul S ^a   Coldman, Andrew J ^a   Goldenberg, S Larry ^a   Tenniswood, Martin ^b   Fox, Kelly ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b Adirondack Biomedical Research Institute Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CLUSTERIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CARCINOMA CELL; CELL CULTURE; CELL DEATH; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOLOGY; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NONHUMAN; STEM CELL; TUMOR GROWTH;

ANDROGENS; ANIMALS; ANTIBODIES; APOPTOSIS; CARCINOMA; CELL DIVISION; CLUSTERIN; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED STRAINS; MOLECULAR CHAPERONES; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RECEPTORS, GLUCOCORTICOID; SUPPRESSION, GENETIC; TESTOSTERONE; TUMOR STEM CELLS;

EID: 0030449469     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(96)00132-X     Document Type: Article

References (52)

1. 1. Bruchovsky N., Rennie P. S., Coldman A. J., Goldenberg S. L., To M. and Lawson D.: Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma. Cancer Res. 50 (1990) 2275-2282.
2. 2. Bruchovsky N., Lesser B., Van Doom E. and Craven S.: Hormonal effects on cell proliferation in rat prostate. Vit. Horm. 33 (1975) 61-102.
3. 3. Bruchovsky N. and Lesser B.: Control of proliferative growth in androgen responsive organs and neoplasms. In Cellular Mechanisms Modulating Gonadal Hormone Action (Edited by Singhal R. L. and Thomas J. A.). University Park Press, Baltimore (1976) pp. 1-55.
4. 4. Rennie P. S., Bruchovsky N., Akakura K., Goldenberg S. L., Otal N., Akakura S., Wong P. and Tenniswood M.: Effect of tumour progression on the androgenic regulation of the androgen receptor, TRPM-2 and YPT1 genes in the Shionogi carcinoma. J. Steroid Biochem. Molec. Biol. 50 (1994) 31-40.
5. 5. Akakura K., Bruchovsky N., Goldenberg S. L., Rennie P. S., Buckley A. R. and Sullivan L. D.: Effects of intermittent androgen suppression on androgen-dependent tumors. Cancer 71 (1993) 2782-2790.
6. 6. Montpetit M. L., Lawless K. R. and Tenniswood M.: Androgen-repressed messages in the rat ventral prostate. Prostate 8 (1986) 25-36.
7. 7. Bettuzzi S., Hiipakka R. A., Gilna P. and Liao S.: Identification of an androgen-repressed mRNA in rat ventral prostate as coding for sulphated glycoprotein 2 by cDNA cloning and sequence analysis. Biochem. J. 257 (1989) 293-296.
8. 8. Kirszbaum L., Sharpe J. A., Murphy B., D'Apice A. J. F., Classon B., Hudson P. and Walker I. D.: Molecular cloning and characterization of the novel, human complement-associated protein, SP-40, 40: a link between the complement and reproductive systems. EMBO J. 8 (1989) 711-718.
9. 9. Rennie P. S., Bruchovsky N., Buttyan R., Benson M. and Cheng H.: Gene expression during the early phases of regression of the androgen-dependent Shionogi mouse mammary carcinoma. Cancer Res. 48 (1988) 6309-6312.
10. 10. Buttyan R., Olsson C. A., Pintar J., Chang C., Bandyk M., Ng P.-Y. and Sawczuk I. S.: Induction of the TRPM-2 gene in cells undergoing programmed death. Molec. Cell. Biol. 9 (1989) 3473-3481.
11. 11. Grima J., Zwain I., Lockshin R. A., Bardin W. and Cheng C. Y.: Diverse secretory patterns of clusterin by epididymis and prostate/seminal vesicles undergoing cell regression after orchiectomy. Endocrinology 126 (1990) 2989-2997.
12. 12. Kyprianou N., English H. F. and Isaacs J. T.: Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res. 50 (1990) 3748-3753.
13. 13. May P. C., Robison P., Fuson K., Smalstig B., Stephenson D. Clemens J. A.: Sulfated glycoprotein-2 expression increases in rodent brain after transient global ischemia. Molec. Brain Res. 15 (1992) 33-39.
14. 14. Tenniswood M. P., Guenette R. S., Lakins J., Mooibroek M., Wong P. and Welsh J.-E.: Active cell death in hormone-dependent tissues. Cancer Metab. Rev. 11 (1992) 197-220.
15. 15. Cheng C. Y., Mathur P. P. and Grima J.: Structural analysis of clusterin and its subunits in ram rete testis fluid. Biochemistry 27 (1988) 4079-4088.
16. 16. Kissinger C., Skinner M. K. and Griswold M. D.: Analysis of Sertoli cell secreted proteins by two-dimensional electrophoresis. Biol. Reprod. 27 (1982) 233-240.
17. 17. Sylvester S. R., Skinner M. K. and Griswold M. D.: A sulfated glycoprotein synthesized by Sertoli cells and by epididymal cells is a component of the sperm membrane. Biol. Reprod. 31 (1984) 1087-1101.
18. 18. Jenne D. E. and Tschopp J.: Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 7123-7127.
19. 19. Choi N. H., Nakano Y., Tobe T., Mazda T. and Tomita M.: Incorporation of SP-40, 40 into the soluble membrane attack complex (SMAC, SC5b-9) of complement. Int. Immun. 2 (1990) 413-417.
20. 20. Jenne D. E. and Tschopp J.: Clusterin, the intriguing guises of a widely expressed glycoprotein. Trends Biochem. Sci. 71 (1992) 154-159.
21. 21. Purrello M., Bettuzzi S., Di Pietro C., Mirabile E., Di Blasi M., Rimini R., Grzeschik K.-H., Ingletti C., Corti A. and Sichel G.: The gene for SP-40, 40, human homolog of rat sulfated glycoprotein 2, rat clusterin, and rat testosterone-repressed prostate message 2, maps to chromosome 8. Genomics 10 (1991) 151-156.
22. 22. French L. E., Wohlwend A., Sappino A.-P., Tschopp J. and Schifferli J. A.: Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J. Clin. Invest. 93 (1994) 877-884.
23. 23. Sensibar J. A., Sutkowski D. M., Raffo A., Buttyan R., Griswold M. D., Sylvester S. R., Kozlowski J. M. and Lee C. L.: Prevention of cell death induced by tumor necrosis factor α in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin). Cancer Res. 55 (1995) 2431-2437.
24. 24. Minesita T. and Yamaguchi T.: An androgen-dependent mouse mammary tumor. Cancer Res. 25 (1965) 1168-1175.
25. 25. Chomczynski P. and Sacchi N.: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt. Biochem. 162 (1987) 156-159.
26. 26. Aviv H. and Leder P.: Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acidcellulose. Proc. Natl. Acad. Sci. U.S.A. 69 (1972) 1408-1413.
27. 27. Leger J. G., Montpetit M. L. and Tenniswood M. P.: Characterization and cloning of androgen-repressed mRNAs from rat ventral prostate. Biochem. Biophys. Res. Commun. 147 (1987) 196-203.
28. 28. Govindan M. V., Devic M., Green S., Gronemeyer H. and Chambon P.: Cloning of the human glucocorticoid receptor cDNA. Nud. Acid Res. 13 (1985) 8293-8304.
29. 29. Cleveland D. W., Lopata M. A., McDonald R. J., Cowan N. J., Rutter W. J. and Kirshner M. W.: Number and evolutionary conservation of α-and β-tubulin and cytoplasmic β-and γ-actin genes using specific cloned cDNA probes. Cell 20 (1980) 95-105.
30. 30. Bruchovsky N., Rennie P. S., Otal N., Vanson A., Giles M. Pontifex H.: Variability of androgen-related phenotypes in the Shionogi mammary carcinoma during growth, involution, recurrence, and progression to hormonal independence. Cancer Res. 45 (1985) 682-689.
31. 31. Furuya Y., Shirasawa H., Sato N., Watabe Y., Simizu B. and Shimazaki J.: Loss of androgen dependency with preservation of functional androgen receptors in androgen-dependent mouse tumour (Shionogi carcinoma 115). J. Steroid Biochem. Molec. Biol. 42 (1992) 569-574.
32. 32. Rennie P. S., Bowden J.-F., Freeman S. N., Bruchovsky N., Cheng H., Lubahn D. B., Wilson E. M., French F. S. and Main L.: Cortisol alters gene expression during involution of the rat ventral prostate. Molec. Endocr. 3 (1989) 703-708.
33. 33. Foulds L.: Neoplastic Development, Vol. I, Academic Press Inc., New York (1969) pp. 69-76.
34. 34. Noble R. L.: Hormonal control of growth and progression in tumors of Nb rats and a theory of action. Cancer Res. 37 (1977) 82-94.
35. 35. Mode C. J.: Multitype Branching Processes. American Elsevier Publishing Company Inc., New York (1971) pp. 8-10.
36. 36. Michel D., Gillet G., Volovitch M., Pessac B., Calothy G. and Brun G.: Expression of a novel gene encoding a 51.5 kD precursor protein is induced by different retroviral oncogenes in quail neuroretinal cells. Oncogene Res. 4 (1989) 127-136.
37. 37. De Silva H. V., Harmony J. A. K., Stuart W. D., Gil C. M. Robins J.: Apolipoprotein J: structure and tissue distribution. Biochemistry 29 (1990) 5380-5389.
38. 38. James R. W., Hochstrasser A. C., Borghini I., Martin B., Pometta D. and Hochstrasser D.: Characterization of a human high density lipoprotein-associated protein, NA1/NA2. Identity with SP-40, 40, an inhibitor of complement-mediated cytolysis. Arter. Thromb. 11 (1991) 645-652.
39. 39. Griswold M. D., Roberts K. and Bishop P.: Purification and characterization of a sulfated glycoprotein secreted by Sertoli cells. Biochemistry 25 (1986) 7265-7270.
40. 40. Collard M. W. and Griswold M. D.: Biosynthesis and molecular cloning of sulfated glycoprotein 2 secreted by rat Sertoli cells. Biochemistry 26 (1987) 3297-3303.
41. 41. Kierszenbaum A. L., Abdullah M., Ueda H., Ping L. and Tres L. L.: Antibodies to rat Sertoli cell secretory proteins recognize antigenic sites in acrosome and tail of developing spermatids and sperm. J. Cell Sci. 91 (1988) 145-153.
42. 42. Kierszenbaum A. L., Abdullah M., Ueda H. and Tres L. L.: Antibodies to rat sperm tail polypeptides recognize Sertoli cell secretory proteins. Molec. Cell. Biochem. 85 (1989) 171-179.
43. 43. Mattmueller D. R. and Hinton B. T.: Clusterin (SGP-2) in epididymal luminal fluid and its association with epididymal spermatozoa in androgen-deprived rats. Molec. Reprod. Dev. 32 (1992) 73-80.
44. 44. Murphy B. F., Kirszbaum L., Walker I. D. and D'Apice A. J.: SP-40, 40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis. J. Clin. Invest. 81 (1988) 1858-1864.
45. 45. Murphy B. F., Saunders J. R., O'Bryan M. K., Kirszbaum L., Walker I. D. and D'Apice A. J.: SP-40, 40 is an inhibitor of C5b-6-initiated haemolysis. Int. Immun. 1 (1989) 551-554.
46. 46. Wilson M. R., Roeth P. J. and Easterbrook-Smith S. B.: Clusterin enhances the formation of insoluble immune complexes. Biochem. Biophys. Res. Commun. 177 (1991) 985-990.
47. 47. Darbre P. D. and King R. J. B.: Progression to steroid insensitivity can occur irrespective of the presence of functional steroid receptors. Cell 51 (1987) 521-528.
48. 48. Wong P., Pineault J., Lakins J., Taillefer D., Léger J., Wang C. Tenniswood M.: Genomic organization and expression of the rat TRPM-2 (clusterin) gene, a gene implicated in apoptosis. J. Biol. Chem. 268 (1993) 5021-5031.
49. 49. Roberts B.: Nuclear location signal-mediated protein transport. Biochem. Biophys. Acta 1008 (1989) 263-280.
50. 50. Dingwall C., Robbins J. and Dilworth S. M.: Characterization of the nuclear location sequence of Xenopus nucleoplasmin. J. Cell Sci. Suppl. 11 (1989) 243-248.
51. 51. Jenster G., Trapman J. and Brinkmann A. O.: Nuclear import of the human androgen receptor. Biochem. J. 293 (1993) 761-768.
52. 52. Colombel M., Olsson C. A., Ng P.-Y. and Buttyan R.: Hormone-regulated apoptosis results from re-entry of differentiated prostate cells onto a defective cell cycle. Cancer Res. 52 (1992) 4313-4319.